NTU Singapore and partners develop new inhaled treatment for severe lung infections
Sănătate
Nanyang Technological University, Singapore Apr 13 2026 Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB to develop a new inhaled treatment aimed at helping patients recover faster from severe lung infections. The treatment is designed to reduce excessive inflammation in the lungs, which can continue even after viruses or bacteria have been
astăzi